AAAAAA
Results: 1-25/59
Authors:
SOCIE G
CAYUELA JM
RAYNAL B
ESPEROU H
FUND X
RAFFOUX C
DEVERGIE A
RIBAUD P
MAROLLEAU JP
PARQUET N
SIGAUX F
BRISON O
GLUCKMAN E
Citation: G. Socie et al., INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION, Leukemia, 12(9), 1998, pp. 1440-1446
Authors:
GADANO A
HADENGUE A
DEVERGIE A
DENIE C
MOREAU R
DEGOTT C
VALLA D
ERLINGER S
GLUCKMAN E
LEBREC D
Citation: A. Gadano et al., LACK OF EFFECTS OF PROSTAGLANDIN E-1 ON HEPATIC BLOOD-FLOW IN HUMAN, Hepatology, 28(4), 1998, pp. 248-248
Authors:
MEIGNIN V
GLUCKMAN E
GAMBARAELLI D
DEVERGIE A
RAMEE MP
JANIN A
SOCIE G
Citation: V. Meignin et al., MENINGIOMA IN LONG-TERM SURVIVORS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(7), 1998, pp. 723-724
Authors:
SOCIE G
DEVERGIE A
GIRINSKI T
PIEL G
RIBAUD P
ESPEROU H
PARQUET N
BRISON O
GLUCKMAN E
Citation: G. Socie et al., TRANSPLANTATION FOR FANCONIS-ANEMIA (FA) - LONG-TERM FOLLOW-UP OF 50 PATIENTS (PTS) TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING, Bone marrow transplantation, 21, 1998, pp. 168-168
Authors:
DEVERGIE A
PARQUET N
GARDERET L
ESPEROU H
SOCIE G
RIBAUD P
GLUCKMAN E
Citation: A. Devergie et al., ADVANTAGES OF GENO IDENTICAL BMT WITH A NON TOXIC CONDITIONING REGIMEN AS FIRST LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 286-286
Authors:
TRAINEAU R
SCIEUX C
AGBALIKA F
RIBAUD P
SOCIE G
ESPEROU H
DEVERGIE A
PARQUET N
BENBUNAN M
GLUCKMAN E
Citation: R. Traineau et al., USE OF FILTERED BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS (CMV) INFECTION AFTER ALLOGENEIC MARROW TRANSPLANT, Bone marrow transplantation, 21, 1998, pp. 475-475
Authors:
GRATWOHL A
HERMANS J
GOLDMAN JM
ARCESE W
CARRERAS E
DEVERGIE A
FRASSONI F
GAHRTON G
KOLB H
NIEDERWIESER D
RUUTU T
VERNANT JP
DEWITTE T
APPERLEY J
Citation: A. Gratwohl et al., RISK ASSESSMENT FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA BEFORE ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION, Lancet, 352(9134), 1998, pp. 1087-1092
Authors:
MEIGNIN V
DEVERGIE A
BRICE P
BRISON O
PARQUET N
RIBAUD P
COJEAN I
GAULARD P
GLUCKMAN E
SOCIE G
JANIN A
Citation: V. Meignin et al., HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA, Transplantation, 65(4), 1998, pp. 595-597
Authors:
ROCHA V
DEVERGIE A
SOCIE G
RIBAUD P
ESPEROU H
PARQUET N
GLUCKMAN E
Citation: V. Rocha et al., UNUSUAL COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA, British Journal of Haematology, 103(1), 1998, pp. 243-248
Authors:
SOCIE G
DEVERGIE A
GIRINSKI T
PIEL G
RIBAUD P
ESPEROU H
PARQUET N
MAAREK O
NOGUERA MH
RICHARD P
BRISON O
GLUCKMAN E
Citation: G. Socie et al., TRANSPLANTATION FOR FANCONI ANEMIA - LONG-TERM FOLLOW-UP OF 50 PATIENTS TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING, British Journal of Haematology, 103(1), 1998, pp. 249-255
Authors:
MEIGNIN V
DEVERGIE A
BRICE P
BRISON O
PARQUET N
RIBAUD P
COJEAN I
GAULARD P
GLUCKMAN E
SOCIE G
JANIN A
Citation: V. Meignin et al., HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 211-211
Authors:
YAKOUBAGHA I
RIBAUD P
DEVERGIE A
GARNIER F
DAMAJ G
ROCHA V
GARDERET L
SELIMI F
GUARDIOLA P
SOCIE G
ESPEROU H
GLUCKMAN E
Citation: I. Yakoubagha et al., BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA (T-MDS) AND ACUTE-LEUKEMIA (T-AL) - EXPERIENCE OF SAINT-LOUIS-HOSPITAL (PARIS), British Journal of Haematology, 102(1), 1998, pp. 317-317
Authors:
VANRHEE F
SZYDLO RM
HERMANS J
DEVERGIE A
FRASSONI F
ARCESE W
DEWITTE T
KOLB HJ
NIEDERWISER D
JACOBSEN N
GAHRTON G
BANDINI G
CARRERAS E
BACIGALUPO A
MICHALLET M
RUUTU T
REIFFERS J
GOLDMAN JM
APPERLEY J
GRATWOHL A
Citation: F. Vanrhee et al., LONG-TERM RESULTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - A REPORT FROM THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Bone marrow transplantation, 20(7), 1997, pp. 553-560
Authors:
DEVERGIE A
APPERLEY JF
LABOPIN M
MADRIGAL A
JACOBSEN N
CARRERAS E
PRENTICE HG
JOUET JP
KOLB HJ
HERSTENSTEIN B
BACIGALUPO A
EVENSEN SA
LJUNGMAN P
DEWITTE T
REIFFERS J
NAGLER A
CLARK RE
GOLDMAN JM
GRATWOHL A
Citation: A. Devergie et al., EUROPEAN RESULTS OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IMPACT OF HLA CLASS-II MATCHING, Bone marrow transplantation, 20(1), 1997, pp. 11-19
Authors:
BRAUNER R
ADAN L
SOUBERBIELLE JC
ESPEROU H
MICHON J
DEVERGIE A
GLUCKMAN E
ZUCKER JM
Citation: R. Brauner et al., CONTRIBUTION OF GROWTH-HORMONE DEFICIENCY TO THE GROWTH FAILURE THAT FOLLOWS BONE-MARROW TRANSPLANTATION, The Journal of pediatrics, 130(5), 1997, pp. 785-792
Authors:
TOUBERT ME
SOCIE G
GLUCKMAN E
ARACTINGI S
ESPEROU H
DEVERGIE A
RIBAUD P
PARQUET N
SCHLAGETER MH
BERESSI JP
RAIN JD
VEXIAU P
Citation: Me. Toubert et al., SHORT-TERM AND LONG-TERM FOLLOW-UP OF THYROID-DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITHOUT THE USE OF PREPARATIVE TOTAL-BODY IRRADIATION, British Journal of Haematology, 98(2), 1997, pp. 453-457
Authors:
RIBAUD P
SCIEUX C
PARQUET N
CARBONNEL E
SOCIE G
EMPEROU H
DEVERGIE A
SELIMI F
GLUCKMAN E
Citation: P. Ribaud et al., PRELIMINARY-RESULTS OF CIDOFOVIR (HPMPC) FOR THE TREATMENT OF ADENOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PATIENTS, Blood, 90(10), 1997, pp. 4432-4432
Authors:
PARQUET N
DEVERGIE A
SOCIE G
RIBAUD P
ESPEROU H
GLUCKMAN E
Citation: N. Parquet et al., VENOOCCLUSIVE DISEASE AFTER BONE-MARROW T RANSPLANTATION - USE OF HEPARIN FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE, Annales de medecine interne, 148(2), 1997, pp. 132-135
Authors:
BACHMEYER C
DEVERGIE A
MANSOURI S
DUBERTRET L
ARACTINGI S
Citation: C. Bachmeyer et al., PYOGENIC GRANULOMA OF THE TONGUE IN CHRON IC GRAFT-VERSUS-HOST DISEASE, Annales de dermatologie et de venereologie, 123(9), 1996, pp. 552-554
Authors:
ARACTINGI S
JANIN A
DEVERGIE A
BOURGES M
SOCIE G
GLUCKMAN E
Citation: S. Aractingi et al., HISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY OF DIFFUSE MELANODERMA AFTER BONE-MARROW TRANSPLANTATION, British journal of dermatology, 134(2), 1996, pp. 325-331
Authors:
DEVERGIE A
GIRINSKI T
SOCIE G
GLUCKMAN E
Citation: A. Devergie et al., IMMUNOSUPPRESSIVE TREATMENT WITH 1 GY LYMPHOID IRRADIATION FOR THE TREATMENT OF SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 88(10), 1996, pp. 2565-2565
Authors:
DEEG HJ
SOCIE G
SCHOCH G
HENRYAMAR M
WITHERSPOON RP
DEVERGIE A
SULLIVAN KM
GLUCKMAN E
STORB R
Citation: Hj. Deeg et al., MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA AND FANCONI-ANEMIA - A JOINT SEATTLE AND PARIS ANALYSIS OF RESULTS IN 700 PATIENTS, Blood, 87(1), 1996, pp. 386-392
Authors:
SOCIE G
BACIGALUPO A
DEVERGIE A
CAROSELLA E
GLUCKMAN E
Citation: G. Socie et al., ACQUIRED APLASTIC-ANEMIA - OPTIMUM IMMUNOSUPPRESSIVE TREATMENT, CLINICAL IMMUNOTHERAPEUTICS, 4(1), 1995, pp. 9-15
Authors:
PARQUET N
LEHMAN D
SCIEUX C
DEVERGIE A
MORINET F
GLUCKMAN E
Citation: N. Parquet et al., MONITORING OF CMV INFECTION AND DISEASE AFTER BONE-MARROW TRANSPLANTATION BY CMV ANTIGEN-DETECTION IN PERIPHERAL-BLOOD LEUKOCYTES, Experimental hematology, 23(8), 1995, pp. 856-856
Authors:
PARQUET N
RIBAUD P
CHASTANG C
LATGE JP
SARFATI J
BAFFROYLAFITTE L
DEVERGIE A
ESPEROUBOURDEAU H
TRAORE F
BOUAKLINE A
DEKERVILER E
GLUCKMAN E
Citation: N. Parquet et al., AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS, Experimental hematology, 23(8), 1995, pp. 856-856